Xvivo Perfusion AB (publ) (STO:XVIVO)
Sweden · Delayed Price · Currency is SEK 295.20
-13.80 (-4.47%)
Aug 14, 2026, 5:29 PM CET
Xvivo Perfusion AB Market Cap
Xvivo Perfusion AB has a market cap or net worth of 9.3 billion as of August 14, 2026. Its market cap has increased by 65.10% in one year.
Market Cap
9.30B
Enterprise Value
9.12B
Revenue
895.23M
Ranking
n/a
PE Ratio
104.99
Stock Price
295.20
ChartMarket Cap Chart
Since October 8, 2012, Xvivo Perfusion AB's market cap has increased from 371.69M to 9.30B, an increase of 2,401.70%. That is a compound annual growth rate of 26.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 9.30B | 58.20% |
| Dec 30, 2025 | 5.88B | -61.84% |
| Dec 30, 2024 | 15.40B | 48.41% |
| Dec 29, 2023 | 10.38B | 90.12% |
| Dec 30, 2022 | 5.46B | -33.55% |
| Dec 30, 2021 | 8.22B | -8.90% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Getinge AB | 65.34B |
| Sectra AB | 53.64B |
| Elekta AB | 20.56B |
| Nolato AB | 13.93B |
| Vitrolife AB | 12.32B |
| MedCap AB | 8.18B |
| CellaVision AB | 3.64B |
| C-Rad AB | 1.22B |